Effect of buprenorphine on psychomotor functions in patients on buprenorphine maintenance

Journal of Opioid Management

Volumn 4, Issue 1, 2008, Pages 41-47

  Singhal, Ankush ^a   Tripathi, B M ^b   Pal, Hem Raj ^c   Jena, Renuka ^d   Jain, Raka ^b  

^a LISTER HOSPITAL   (United Kingdom)

^b ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^c North East Essex Drug and Alcohol Service ^*  (United Kingdom)

^d EAST LONDON NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Buprenorphine; Maintenance treatment; Opioid dependence; Psychomotor effects

Indexed keywords

ALCOHOL; BENZODIAZEPINE DERIVATIVE; BUPRENORPHINE; CANNABIS; DIAMORPHINE;

ADULT; ARTICLE; CLINICAL ARTICLE; DRUG DEPENDENCE TREATMENT; DRUG EFFICACY; FEMALE; HUMAN; MAINTENANCE DRUG DOSE; MALE; MENTAL TASK; OPIATE ADDICTION; OUTCOME ASSESSMENT; PSYCHOLOGIC TEST; PSYCHOMOTOR ACTIVITY; PSYCHOMOTOR PERFORMANCE; TREATMENT DURATION;

EID: 41549127492     PISSN: 15517489     EISSN: None     Source Type: Journal    
DOI: 10.5055/jom.2008.0007     Document Type: Article

References (33)

1. Singhal A, Tripathi BM, Pal HR, et al.: Subjective effects of additional doses of buprenorphine in patients on buprenorphine maintenance. Addict Behav. 2007; 32: 320-331.
2. Preston KL, Bigelow GE, Liebson IA: Burenorphine and naloxone alone and in combination in opioid-dependent humans. Psychopharmacol. (Berl) 1988; 94: 484-490.
3. Strain EC, Preston KL, Liebson IA, et al.: Acute effects of buprenorphine, hydromorphone and naloxone in methadone-maintained volunteers. J Pharmacol Exp Ther. 1992; 261: 985-993.
4. Walsh SL, June HL, Schuh KJ, et al.: Effects of buprenorphine and methadone in methadone maintained subjects. Psychopharmacol. (Berl) 1995; 119: 268-276.
5. Giacomuzzi SM, Ertl M, Vigl A, et al.: Driving capacity of patients treated with methadone and slow-release oral morphine. Addiction. 2005; 100: 1027.
6. Strain EC, Walsh SL, Preston KL, et al.: The effects of buprenorphine in buprenorphine maintained volunteers. Psychopharmacol. (Berl) 1997; 129: 329-338.
7. Wechsler D: Manual: Wechsler Adult Intelligence Scale - Revised (WAIS-R). New York: Psychological Corporation, 1981.
8. Reitan RM, Wolfson D: The Halstead-Reitan neuropsychological test battery: Theory and Clinical Interpretation. Tucson, AZ: Neuropsychology Press, 1993.
9. Lezak MD: Neuropsychological Assessment. Oxford: Oxford University Press, 1995.
10. Pershad D: Construction and Standardization of Clinical Test of Memory in Simple Hindi. Agra, India: National Psychological Corporation, 1977: 124.
11. Jam R: Analytical methods. In Jain R (ed.): Detection of Drugs of Abuse in Body Fluids - A Manual for Laboratory Personnel. New Delhi: Drug Dependence Treatment Centre, AIIMS, 1998.
12. Anderson G, Thomson AB, Jensen NH, et al.: Cerebral dysfunction after prolonged use of opioids. Ugeskr Laeger. 1993; 155: 3459-3462. Review.
13. Zacny JP, Conley K, Galinkin J: Comparing the subjective psychomotor and physical effects of intravenous buprenorphine and morphine in healthy volunteers. J Pharmacol Exp Ther. 1997; 282: 1187-1197.
14. Jones HE, Bigelow GE, Preston KL: Assessment of opioid partial agonist activity with a 3 choice hydromorphone dose discrimination procedure. J Pharmacol Exp Ther. 1999; 289: 1350-1361.
15. Preston KL, Bigelow GE, Bickel WK, et al.: Drug discrimination in human post addicts: Agonist-antagonist opioids. J Pharmacol Exp Ther. 1989; 250: 184-196.
16. Preston KL, Bigelow GE: Drug discrimination assessment of agonist-antagonist opiates in humans. A three-choice saline-hydromorphone-butorphenol procedure. J Pharmacol Exp Ther. 1994; 271: 48-60.
17. Preston KL, Bigelow GE: Effects of agonist and antagonist opiates in humans trained in a hydromorphone - Not hydromorphone discrimination. J Pharmacol Exp Ther. 2000; 295: 114-124.
18. Strain EC, Stoller K, Walsh SL, et al.: Effects of buprenorphine versus buprenorphine/naloxone tablets in non-dependent opioid abusers. Psychopharmacol. (Berl) 2000; 148: 374-383.
19. Walsh SL, Preston KL, Stitzer ML, et al.: Clinical pharmacology of buprenorphine: Ceiling effects at high doses. Clin Pharmacol Ther. 1994; 55: 569-580.
20. Weinhold LL, Preston KL, Farre M, et al.: Buprenorphine alone and in combination with naloxone in nondependent humans. Drug Alcohol Depend. 1992; 30: 263-274.
21. Zacny JP: A review of the effects of opiates on psychomotor and cognitive functioning in humans. Exp Clin Psychopharm. 1995; 3: 432-466.
22. Hanks GW, O'Neill WM, Simson P, et al.: The cognitive and psychomotor effects of opioid analgesics-II. A randomized controlled trial of single doses of morphine, lorazepam and placebo in healthy subjects. Eur J Clin Pharmacol. 1995; 48: 455-460.
23. O'Neill WM, Hanks GW, Simpson P, et al.: The cognitive and psychomotor effects of morphine in healthy subjects: A randomized controlled trial of repeated (four) oral doses of dextropropoxyphene, morphine, lorazepam and placebo. Pain. 2000; 85: 209-215.
24. Haythornwaite JA, Menefee LA, Qurtrano Piacentini AL, et al.: Outcome of chronic opioid therapy for non-cancer pain. J Pain Symptom Manage. 1998; 15: 185-194.
25. Jamison RN, Schein JR, Vallow S, et al.: Neuropsychological effects of long-term opioid use in chronic pain patients. J Pain Symptom Manage. 2003; 26: 913-921.
26. Johnson RE, Jaffe JH, Fudala PJ: A controlled trial of buprenorphine treatment for opioid dependence. JAMA. 1992; 267: 2750-2755.
27. Ling W, Charuvastra C, Collins JF, et al.: Buprenorphine maintenance treatment of opiate dependence: A multicenter, randomized clinical trial. Addiction. 1998; 93: 475-486.
28. Mohan D, Ray R: Community Based Treatment for Heroin Dependence in an Urban Slum of Delhi (India). Report submitted to WHO, SEARO, New Delhi, India, 1997.
29. O'Neill WM: The cognitive and psychomotor effects of opioid drugs in cancer pain management. Cancer Surveys. 1994; 21: 67-84.
30. Sjogren P, Olsen AK, Thomson AB, et al.: Neuropsychological performance in cancer patients. The role of oral opioids, pain and performance status. Pain. 2000; 86: 237-245.
31. Sjogren P, Thomsen AB, Olsen AK: Impaired neuropsychological performance in chronic non malignant pain patients receiving long term oral opioid therapy. J Pain Symp Manage. 2000; 9: 100-108.
32. Bruera E, Macmillan K, Hansen J, et al.: The cognitive effects of administration of narcotic analgesics in patients with cancer pain. Pain. 1989; 39: 13-16.
33. Sjogren P: Psychomotor and cognitive functioning in cancer patients. Acta Anaesthesiol Scand. 1997; 41: 159-161.